{"name":"Steminent Biotherapeutics Inc.","slug":"steminent-biotherapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Adipose-Derived Mesenchymal Stem Cells","genericName":"Adipose-Derived Mesenchymal Stem Cells","slug":"adipose-derived-mesenchymal-stem-cells","indication":"Orthopedic injuries","status":"phase_2"}]}],"pipeline":[{"name":"Adipose-Derived Mesenchymal Stem Cells","genericName":"Adipose-Derived Mesenchymal Stem Cells","slug":"adipose-derived-mesenchymal-stem-cells","phase":"phase_2","mechanism":"Adipose-derived mesenchymal stem cells modulate immune responses and promote tissue repair through paracrine signaling and differentiation into multiple cell types.","indications":["Orthopedic injuries","Autoimmune diseases","Wound healing"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNLTRtcTk2bGcweXN0X3B2UzFKLVV2R1lqbjV2NUVSVE1iMmQxTDFpekRIbVpYMDJ2TFVjYXItLTAtQkIzZGpvMGdQQjhwM1Ficms1N3dBUVFaTnBEY01qaWNieDg4QThrYWhxbDJFTndkcFpmT1JnWnR1NGJhVThQX2lhcmVIZG1uMEJacGtjQ0N3ZFJZZThJd1ZjazFyaFEwZnAweEtXdktQNUw0THRuc3JiYnNiR0o5VUNkN2pNOGJyeHFJNC10SXlpZk5fWlM1U254QW10RHZoamJLZkxLdW41YXBWQQ?oc=5","date":"2025-10-06","type":"pipeline","source":"Plataforma Media","summary":"Taiwan Pavilion Fostering Collaborative Innovation in AI, Regenerative Medicine and CDMO at BioJapan 2025 - Plataforma Media","headline":"Taiwan Pavilion Fostering Collaborative Innovation in AI, Regenerative Medicine and CDMO at BioJapan 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNT2NQRXUxR1F6bEtKa0taYS1rM1BxdXdMcV9wN0tyY2xMMmhEbW0xdUQxdXFBa29RU1MwZkx4alBwSEYzYjljVGdxdi1yTzA3c0tTSWNnTmRrMFFqWmNsSmRjcjNDdTJ6bVRxclhvZEZka0JELXJXMjNUaGdDQzRUZ2lsSmNIS2xBWENJVnducy1nTlFscmxmZzNMVW5iaXNoNlV1Q1ptaGl1QnV1LUQwbUlPR2s0Qk14VnEydU5rX2ZUWldWQk92eGEySE5XZ3FsRDdZbA?oc=5","date":"2025-07-22","type":"regulatory","source":"geneonline.com","summary":"Steminent Takes Global Stage with Stemchymal Data, Fuels Japan Regulatory Filing and International Partnerships - geneonline.com","headline":"Steminent Takes Global Stage with Stemchymal Data, Fuels Japan Regulatory Filing and International Partnerships","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxOUmtMUnFOUGRxVXdkSFBFS1BWOTJCMXliTVNxdHVpNjF0MEpjYzR4bnFMXzJsZ2lGWHgtOC1ienEzSXZfUnd0WXB0S2xSQ1V5aWsyVnYyNzZsREdCTzNnWl9kVFJNQW5TX29tdHVQTDFTSU9rUzNGVVhmSUw5cXFhY3BYTjZnQ1gzTi1qOXI4ekNxXzdHb3Nnc3lNLXFfYS15MHI5c0hIaUViU3BHZk40T25hTGVmMWtmeEZaUUFYZzRQZGdpejAxMnU2MzB2bnVyWXJ6MklhMEhkQlFZalg1RDZXSDQtcGZjWGVRUmVpVF9GRWc?oc=5","date":"2025-04-24","type":"pipeline","source":"PR Newswire","summary":"Steminent to Showcase Breakthrough MSC-based Therapy for Spinocerebellar Ataxia at WODC USA and ISCT 2025 - PR Newswire","headline":"Steminent to Showcase Breakthrough MSC-based Therapy for Spinocerebellar Ataxia at WODC USA and ISCT 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBPdHhZU0NYUTBSN1huR2RFbE0tcVRaWWs0NHpyZm1DaGtYQTlZd3dHLW1NcVliVVlpWlF3UEtIM1lIUGF6REdWQzJNRzhFZW5QbWVQNnE4azY4WS1KbDJUbExFN3pmN3pPZEJzTTlnWmE?oc=5","date":"2025-03-05","type":"pipeline","source":"Labiotech.eu","summary":"The 7 hottest biotech companies in Taiwan - Labiotech.eu","headline":"The 7 hottest biotech companies in Taiwan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxQVGpzVFNqYVB4cWl2VWYyVFJpT2xrY0Yyam56ZEwySDZsZ1lvV3B4elZ1cXNRcXZnUkF3WXVid0kwRHBza0RwVk0tSWtWMmtXaVM5eEt5aERGMW9aZzMtWkJzZ29jSzJObE0xYXFJQ1pFRFJhRHNFc3Vuak5pblpUd2VKM1o0Z2FrTmZvSHpKOHZ0WThrT2thRFRKOTJ3al9NYVV5UU5QSVp6aGFMMkJhNGhrS3RwWjFpRGxxREJZRUNxSUNqT1Bncy1rcFFVamppV3ZhM0hRMGtTR1M3WVJQcUpaN1BoR19oWEFDdHBXZTNJVGNiVkw3LVNBcW5COENqUWwtUXlZcjZoTmM5QzBZS2NmZ043aG9EbUJtZjZ0UmZxSmJhMG1icFNsZTRsMHp6LUZsNXFHOEZzRlFQVXpoc20xVWhCRXV4S29rOHF3?oc=5","date":"2023-09-07","type":"pipeline","source":"PR Newswire","summary":"Acute-On-Chronic Liver Failure Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Grifols, Promethera, GENFIT, RHEACELL, Versantis, Martin GNI Group - PR Newswire","headline":"Acute-On-Chronic Liver Failure Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Grifol","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOckNPSF91U0hYcDlrTzBBdkFiZEtTX2REaDVqUnZQYTZuTlczQnN5RWxHUFFTTmNIamlNS0o5SHJIaTNMdWRRRVFfR2ZGZDlpeDFHTDhkcVh2VFVLZmxhWnJQdHdIOENrVVNQV2t1akVMb2NyWjkwdWRIOTRETXctd1B0c0zSAYoBQVVfeXFMTUViQWlqbzhZQTFPLUotc1RCOGpJSDA2a2o0V2FDSURwRjZ6eU5aelJOaGwtelFwRW1jNkhMU3RXT1NyeDU4WHlqMjJaNlJGSktXZmhJVFhVaVRsejhacHpTV1luZHpXbXdaMkR0VTgyR0dOaFZyeDNpWnVHZDNkV04tdEFUaWNhbDdn?oc=5","date":"2020-10-13","type":"deal","source":"BioInformant","summary":"Steminent Biotherapeutics licenses rights to SCM Lifescience to develop Stemchymal® cell therapy for treating spinocerebellar ataxia (SCA) in South Korea - BioInformant","headline":"Steminent Biotherapeutics licenses rights to SCM Lifescience to develop Stemchymal® cell therapy for treating spinocereb","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE05Vk9xaldzZzhpZm4tT0hHMnByTGQwQjA3c2FhbE9CNXNDUWRaRkxhYnhFSm5XczRUWm9zR0FlcXh3Y1RhUkJwMVE2WUtjald2YU45eUFOb2hrU21CSWfSAWNBVV95cUxONGFyUnEyMlVjV2VFakN3QmVDRDl6ejBRb1ZRX05VbnVtMmVpZHJnNUM3WEdnRWZPM0ZnWGtVMkh0T2pHeTlJWjc1WUZwZkFEQ1Z6WXYzVXJndFFPT0p2QnVlckk?oc=5","date":"2018-08-07","type":"regulatory","source":"BioInformant","summary":"Steminent Announces Japan partner ReproCELL has PMDA Approval of CTN for Phase II Trial of Stemchymal® SCA in the Treatment of Spinocerebellar Ataxia in Japan - BioInformant","headline":"Steminent Announces Japan partner ReproCELL has PMDA Approval of CTN for Phase II Trial of Stemchymal® SCA in the Treatm","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFBiMW5ocGJGMm1fYTBBSW1ObFdKTmxzbHI1Tk5MQXNyLXZKNlNfZDh4TC1BX1hCSUdQT25XQk9WcGlFdGd4em1xVUU5TUczV2RBOHNFSVFja0loYWYycXZMYjhB0gFnQVVfeXFMTnRmUUVLWUdYVDBvU1QtTkF3RVdCcjFiMVpFTDJaeDRiX1ZvbTRFNEtDWFhxaGZQLW1nWXdGdXpzbnBNQ29TNEpDUUVQU2s5bnR1YmFCcjVSM3prdFRfOEdabm5HNmtrOA?oc=5","date":"2018-07-18","type":"regulatory","source":"BioInformant","summary":"Steminent Announces FDA Approval of IND for Phase II Clinical Trial of Stemchymal® SCA in the Treatment of Spinocerebellar Ataxia - BioInformant","headline":"Steminent Announces FDA Approval of IND for Phase II Clinical Trial of Stemchymal® SCA in the Treatment of Spinocerebell","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE8yMDJCbWtyRHhKbEZidGpuU0ZCeFdiSDgwNmVzZGNSRnNMTV93N1FxaWVRaHlyVzltTWY1cmpYZy1WOVRVZUZ5TG1fNHNzckpGTHM2aU03U0dSMUc0LWfSAWNBVV95cUxQWkxfdUgyaXFWZ3d1a0RRbFp3N3RDUXZqeHhJeUFzUUtQTFRSYlVmb2JJQmhmRGtRRTZxdmpVWWwxOXZJOGVmYks2OF9RMi16T0N3al9iYkhGTXhTRUJfZkl3cFU?oc=5","date":"2016-12-26","type":"deal","source":"BioInformant","summary":"ReproCELL and Steminent Partner to Commercialize Stemchymal in Japan - BioInformant","headline":"ReproCELL and Steminent Partner to Commercialize Stemchymal in Japan","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}